The emerging role of neutrophil granulocytes in multiple sclerosis

Tonia Woodberry, Sophie E. Bouffler, Alicia S. Wilson, Rebecca L. Buckland, Anne Brüstle*

*Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    59 Citations (Scopus)

    Abstract

    Multiple sclerosis (MS) is a demyelinating disease of the central nervous system with a strong autoimmune, neurodegenerative, and neuroinflammatory component. Most of the common disease modifying treatments (DMTs) for MS modulate the immune response targeting disease associated T and B cells and while none directly target neutrophils, several DMTs do impact their abundance or function. The role of neutrophils in MS remains unknown and research is ongoing to better understand the phenotype, function, and contribution of neutrophils to both disease onset and stage of disease. Here we summarize the current state of knowledge of neutrophils and their function in MS, including in the rodent based MS model, and we discuss the potential effects of current treatments on these functions. We propose that neutrophils are likely to participate in MS pathogenesis and their abundance and function warrant monitoring in MS.

    Original languageEnglish
    Article number511
    JournalJournal of Clinical Medicine
    Volume7
    Issue number12
    DOIs
    Publication statusPublished - 1 Dec 2018

    Fingerprint

    Dive into the research topics of 'The emerging role of neutrophil granulocytes in multiple sclerosis'. Together they form a unique fingerprint.

    Cite this